OverviewChartNewsTraderScreen

BOBLTQ LEONGUE C 03/26/  CH0315251790  /

SIX Structured Products
6/13/2025  10:10:00 PM Chg.0.000 Bid6/13/2025 Ask11/2/2022 Underlying Strike price Expiration date Option type
88.330CHF 0.00% -
Bid Size: 0		 -
Ask Size: 0		 NESTLE N - CHF 3/24/2026 Call
GlobeNewswire 6/11 The Countdown Begins: With One Year to Go Until the FIFA World Cup 26™, KC2026 Unveils Official Coun...
GlobeNewswire 6/11 Startup Outset Raises $17M Series A to Help Enterprises Scale & Accelerate Customer Research with AI...
GlobeNewswire 6/10 Vyla announces new CEO
GlobeNewswire 6/2 Mediafly Enhances AI Revenue Enablement Suite with Appinium Acquisition
GlobeNewswire 6/2 Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 De...
GlobeNewswire 5/28 Nespresso and The Weeknd: Creativity Brewed Together
GlobeNewswire 5/7 Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
TeleTrader 4/25 Nestle names Hamilton as new Americas CEO
TeleTrader 4/24 Nestle's Q1 sales up 2.3% to 22.6B Swiss francs
GlobeNewswire 4/22 Teads Celebrates Major Milestone as CTV HomeScreen Powers 1,500 Campaigns
TeleTrader 4/21 Earnings preview: Alphabet, Tesla, Intel and more
Newsfile Corp 4/3 Reuters Events and The Nature Friendly Farming Network Co-Host Live Interview with Nestle on Buildin...
GlobeNewswire 3/13 Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business...
TeleTrader 2/24 Swiss SMI index reaches fresh all-time high
TeleTrader 2/13 Nestle jumps 6% after dividend hike
TeleTrader 2/13 Nestle's 2024 sales fall 1.8% to 91.35B Swiss francs
TeleTrader 11/19/2024 Europe opens higher ahead of inflation print
TeleTrader 11/19/2024 Nestle sees organic growth at 4% in medium term
TeleTrader 10/17/2024 Europe premarket lower to flat with eyes on ECB's rate decision
TeleTrader 10/17/2024 Nestle sales down 2.4% to 67.1B Swiss francs in 9M
TeleTrader 8/22/2024 Nestle appoints Laurent Freixe as new CEO
GlobeNewswire 8/13/2024 Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire 8/6/2024 Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
TeleTrader 7/25/2024 Europe lower premarket as earnings pour in
TeleTrader 7/25/2024 Nestle sales down 3% to 45B Swiss francs in H1